Doctor profile · Federal record
Dr. ALKA REBENTISH, MD
Infectious Disease Physician (CMS: INFECTIOUS DISEASE) · LAS VEGAS, NV
- NPI 1427012806
- Accepts Medicare
- 45 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
6088 S DURANGO DR STE 100
LAS VEGAS, NV 891131780
(702) 380-4242
fax (702) 380-4141 - Mailing address
-
1450 W HORIZON RIDGE PKWY, B304 #668
HENDERSON, NV 89012
Credentials & registration
- NPI registered
- April 2006 — 20 yrs on file
- Profile last updated
- April 24, 2025
- Year of graduation
- 1981 — 45 yrs since
- Specialty taxonomy
- 207RI0200X — NUCC code
- State license (1)
- Nevada #8061
- Medicaid
- NV #2002678
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1427012806. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
636
Distinct HCPCS
7
Medicare allowed
$80,194
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 313 | 181 | $118 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 109 | 105 | $172 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 102 | 78 | $126 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 56 | 47 | $87 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 25 | 25 | $164 | |
99442 |
Telephone medical discussion with physician, 11-20 minutes | 17 | 15 | $67 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 14 | 14 | $112 |
In context: peer comparison
Among 21 peers in this city , average services per provider: 3,511. This provider delivers 0.2× the peer median.Open Payments
Industry payments received
All-time total
$2,698
Transactions
112
Manufacturers
13
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ViiV Healthcare Company | 40 | $881.78 | |
| Gilead Sciences, Inc. | 15 | $295.98 | |
| Astellas Pharma US Inc | 7 | $276.08 | |
| ABBVIE INC. | 12 | $244.59 | |
| Merck Sharp & Dohme LLC | 8 | $191.57 | |
| Melinta Therapeutics, LLC | 4 | $187.60 | |
| Ferring Pharmaceuticals Inc. | 6 | $162.42 | |
| Shionogi Inc | 10 | $143.34 | |
| AstraZeneca Pharmaceuticals LP | 1 | $121.15 | |
| Insmed, Inc. | 4 | $92.87 | |
| Paratek Pharmaceuticals, Inc. | 3 | $56.21 | |
| AIMMUNE THERAPEUTICS, INC. | 1 | $25.79 | |
| Napo Pharmaceuticals Inc | 1 | $18.38 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
677
Patients
121
Total drug cost
$1,433,605
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Biktarvy (Bictegrav/Emtricit/Tenofov Ala) | Brand | 260 | 34 | $1,060,361 |
| Dovato (Dolutegravir Sodium/Lamivudine) | Brand | 54 | 0 | $161,489 |
| Ceftriaxone (Ceftriaxone Sodium) | Brand | 49 | 18 | $3,229 |
| Daptomycin | Generic | 41 | 0 | $58,812 |
| Isoniazid | Generic | 36 | 0 | $272 |
| Cefepime Hcl | Generic | 32 | 0 | $10,680 |
| Cephalexin | Generic | 31 | 11 | $430 |
| Triumeq (Abacavir/Dolutegravir/Lamivudi) | Brand | 25 | 0 | $97,474 |
| Ertapenem (Ertapenem Sodium) | Brand | 24 | 16 | $12,881 |
| Fluconazole | Generic | 22 | 11 | $811 |